Effects of a novel hepatitis B anti-viral drug E-CFCP in renal organic acid transporters
Currently, the emergence of drug resistance is an important issue in the treatment of hepatitis B virus (HBV). Recently, our collaborating group developed a novel long-acting anti-HBV drug, E-CFCP. However, until this study, the effects of E-CFCP in the kidney have remained unclarified. Using cell v...
Main Authors: | Misaki Ishibane, Hirofumi Hashimoto, Meika Kaneko, Shota Saito, Sangjon Pae, Shinpei Saito, Yoshie Reien, Yuri Hirayama, Nobuyo Higashi-Kuwata, Hiroaki Mitsuya, Naohiko Anzai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Journal of Pharmacological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S134786132200069X |
Similar Items
-
Central administered xenin induced Fos expression in nesfatin-1 neurons in rats
by: Shota Saito, et al.
Published: (2023-11-01) -
HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 Subtypes
by: Maria E. Cilento, et al.
Published: (2023-09-01) -
Current Treatment of HIV Infection
by: Behice KURTARAN
Published: (2015-12-01) -
A study on individualized regimen for north Indians living with human immunodeficiency virus-1 subtype C: A public health approach
by: Ashwini Yadav, et al.
Published: (2023-01-01) -
Targeting L-type amino acid transporter 1 in urological malignancy: Current status and future perspective
by: Sangjon Pae, et al.
Published: (2022-12-01)